• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾脏激肽释放酶-激肽系统在钠和水转运中的作用及其在吲哚美辛影响下的变化]

[Role of the kallikrein-kinin system of the kidneys in sodium and water transport and changes in it under the influence of indomethacin].

作者信息

Nekrasova A A, Zharova E A, Sokolova R I

出版信息

Biull Eksp Biol Med. 1977 Apr;83(4):399-400.

PMID:857964
Abstract

A direct relationship between the level of the kallikrein activity in the urine, and diuresis, natriuresis and the capacity of the kidneys to concentrate the urine in healthy rats was revealed. Low doses of indometacin (2 mg/kg, for 5 days) increased the kallikrein activity in the urine four-fold, with a simultaneous rise of diuresis; high doses (5 mg/kg, for 5 days) cut the kallikrein activity in the urine by half and decreased natriuresis three-fold. At the same time there was also a decreased capacity to concentrate the urine. Thus, indometacin changed not only the prostaglandine synthesis, but also that of kallikrein, this influencing the functional state of the kidney.

摘要

在健康大鼠中,尿液中激肽释放酶活性水平与利尿、利钠以及肾脏浓缩尿液的能力之间存在直接关系。低剂量消炎痛(2毫克/千克,持续5天)使尿液中激肽释放酶活性增加四倍,同时利尿增加;高剂量(5毫克/千克,持续5天)使尿液中激肽释放酶活性减半,利钠减少三倍。与此同时,肾脏浓缩尿液的能力也降低。因此,消炎痛不仅改变了前列腺素的合成,还改变了激肽释放酶的合成,从而影响肾脏的功能状态。

相似文献

1
[Role of the kallikrein-kinin system of the kidneys in sodium and water transport and changes in it under the influence of indomethacin].[肾脏激肽释放酶-激肽系统在钠和水转运中的作用及其在吲哚美辛影响下的变化]
Biull Eksp Biol Med. 1977 Apr;83(4):399-400.
2
The renal kallikrein-kinin system in various types of diuresis and under the effects of inhibitors of prostaglandin synthesis in rats.大鼠不同类型利尿状态下及前列腺素合成抑制剂作用下的肾激肽释放酶-激肽系统
Cor Vasa. 1978;20(6):400-8.
3
[Kidney kallikrein-kinin system in different mechanisms of diuresis].[肾脏激肽释放酶-激肽系统在不同利尿机制中的作用]
Biull Eksp Biol Med. 1977 Aug;84(8):141-3.
4
[Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].[呋塞米与肾脏前列腺素及激肽释放酶-激肽系统的相互作用]
Farmakol Toksikol. 1986 Mar-Apr;49(2):21-4.
5
Urinary kallikrein in postobstructive diuresis.梗阻后利尿中的尿激肽释放酶
Invest Urol. 1980 Jan;17(4):320-3.
6
Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.速尿诱导利尿过程中肾脏激肽释放酶 - 激肽系统与前列腺素系统之间的相互关系。
Urol Int. 1984;39(1):52-7. doi: 10.1159/000280945.
7
[Role of the prostaglandin-kinin system of the kidneys in the transport of sodium and water].
Kardiologiia. 1977 Mar;17(3):108-14.
8
Involvement of the renal kallikrein-kinin system in K(+)-induced diuresis and natriuresis in anesthetized rats.
Eur J Pharmacol. 2000 Jul 7;399(2-3):223-7. doi: 10.1016/s0014-2999(00)00382-4.
9
[Role of prostaglandin, the kallikrein-kinin system and renal dopamine receptors in the mechanism of the natriuretic action of the beta-adrenoblocker obzidan].[前列腺素、激肽释放酶-激肽系统及肾多巴胺受体在β-肾上腺素能阻滞剂奥昔旦利钠尿作用机制中的作用]
Farmakol Toksikol. 1983 Sep-Oct;46(5):56-9.
10
[Regulation of natriuresis in diabetic nephropathy].[糖尿病肾病中利钠作用的调节]
Ann Acad Med Stetin. 2000;46:241-52.